Universität zu Köln

Journal Article

Scheel, Andreas H., Lamberty, Hannah, Tolkach, Yuri ORCID: 0000-0001-5239-2841, Gebauer, Florian ORCID: 0000-0001-5312-4814, Schoemig-Markiefka, Birgid ORCID: 0000-0003-1893-8796, Zander, Thomas ORCID: 0000-0002-4266-6818, Büttner, Reinhard ORCID: 0000-0001-8806-4786, Rueschoff, Josef, Bruns, Christiane J. ORCID: 0000-0001-6590-8181, Schröder, Wolfgang ORCID: 0000-0002-8700-069X and Quaas, Alexander ORCID: 0000-0002-3537-6011 (2023). Tumour area infiltration and cell count in endoscopic biopsies of therapy-naive upper GI tract carcinomas by QuPath analysis: implications for predictive biomarker testing. Scientific Reports, 13 (1). p. 17580. Springer Nature. ISSN 2045-2322

Tolkach, Yuri ORCID: 0000-0001-5239-2841, Ovtcharov, Vlado, Pryalukhin, Alexey, Eich, Marie-Lisa ORCID: 0000-0002-8601-4598, Gaisa, Nadine Therese, Braun, Martin, Radzhabov, Abdukhamid ORCID: 0000-0003-1948-5792, Quaas, Alexander ORCID: 0000-0002-3537-6011, Hammerer, Peter, Dellmann, Ansgar, Hulla, Wolfgang, Haffner, Michael C., Reis, Henning, Fahoum, Ibrahim, Samarska, Iryna ORCID: 0000-0003-4092-0672, Borbat, Artem ORCID: 0000-0002-9699-8375, Pham, Hoa, Heidenreich, Axel ORCID: 0000-0002-2511-3664, Klein, Sebastian ORCID: 0000-0002-2188-9377, Netto, George, Caie, Peter and Büttner, Reinhard ORCID: 0000-0001-8806-4786 (2023). An international multi-institutional validation study of the algorithm for prostate cancer detection and Gleason grading. npj Precision Oncology, 7 (1). p. 77. Springer Nature. ISSN 2397-768X

Simon, Adrian Georg ORCID: 0000-0002-2709-863X, Lyu, Su Ir ORCID: 0009-0002-4125-6048, Laible, Mark, Wöll, Stefan, Türeci, Özlem, Şahin, Uğur, Alakus, Hakan ORCID: 0000-0002-3889-3276, Fahrig, Luca, Zander, Thomas ORCID: 0000-0002-4266-6818, Büttner, Reinhard ORCID: 0000-0001-8806-4786, Bruns, Christiane Josephine ORCID: 0000-0001-6590-8181, Schröder, Wolfgang ORCID: 0000-0002-8700-069X, Gebauer, Florian ORCID: 0000-0001-5312-4814 and Quaas, Alexander ORCID: 0000-0002-3537-6011 (2023). The tight junction protein claudin 6 is a potential target for patient-individualized treatment in esophageal and gastric adenocarcinoma and is associated with poor prognosis. Journal of Translational Medicine, 21 (1). p. 552. Springer Nature. ISSN 1479-5876